PreveCeutical Medical Inc. (OTCMKTS:PRVCF – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $0.01 and traded as low as $0.0082. PreveCeutical Medical shares last traded at $0.0082, with a volume of 180,000 shares traded.
PreveCeutical Medical Price Performance
The stock has a 50-day moving average of $0.01 and a 200-day moving average of $0.01.
PreveCeutical Medical Company Profile
PreveCeutical Medical Inc is a Canadian life sciences company focused on developing preventive and therapeutic healthcare products that combine naturally derived compounds with biotechnology. Its research programs have centered on novel peptide therapies, cannabinoid-based treatments, gene therapy and drug-delivery technologies.
The company’s development portfolio has included a Sol-Gel platform designed to support the delivery of therapeutic compounds, as well as research into dual-gene therapies and synthetic peptides for potential applications in areas such as chronic disease, pain management and other unmet medical needs.
Further Reading
- Five stocks we like better than PreveCeutical Medical
- Starbucks Says Its Turnaround Is Done—The Numbers Make a Strong Case (With 1 Catch)
- 3 Robotics ETFs, 3 Different Ways to Bet on Humanoid Robots
- Can Microsoft Turn a Leaner Workforce and Record AI Spending Into Bigger Profits?
- Why JFrog Could Be the Software Infrastructure Company to Beat in the AI Boom
Receive News & Ratings for PreveCeutical Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PreveCeutical Medical and related companies with MarketBeat.com's FREE daily email newsletter.
-ltd-logo-1200x675.png){kind=logo}
